OSIR - Osiris Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
+0.175 (+2.333%)
At close: 3:01PM EDT
Stock chart is not supported by your current browser
Previous Close7.500
Bid0.000 x 0
Ask0.000 x 0
Day's Range7.430 - 7.550
52 Week Range4.200 - 9.980
Avg. Volume30,495
Market Cap264.986M
PE Ratio (TTM)30.70
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters6 months ago

    Former Osiris Therapeutics executive pleads guilty to false statements

    A former chief financial officer of biotechnology company Osiris Therapeutics on Thursday pleaded guilty to making false statements to auditors to inflate the company's reported revenue. Philip Jacoby, 65, entered his plea before U.S. District Judge Denise Cote in in Manhattan, while Osiris separately agreed to pay $1.5 million to settle a related civil lawsuit by the U.S. Securities and Exchange Commission, court records showed. As part of the plea, Jacoby and prosecutors agreed that an appropriate sentence under federal guidelines would be four to 10 months in prison and a fine of up to $5 million.

  • We're sorry this is all we were able to find about this topic.